Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

PET/CT Imaging of Cardiac Angiotensin II Type 1 Receptors in Nonobstructive Hypertrophic Cardiomyopathy.

Valenta I, Szabo Z, Mathews WB, Abraham TP, Abraham MR, Schindler TH.

JACC Cardiovasc Imaging. 2019 Sep;12(9):1895-1896. doi: 10.1016/j.jcmg.2019.03.022. Epub 2019 May 15. No abstract available.

PMID:
31103588
2.

Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model).

Bhattacharya M, Lu DY, Kudchadkar SM, Greenland GV, Lingamaneni P, Corona-Villalobos CP, Guan Y, Marine JE, Olgin JE, Zimmerman S, Abraham TP, Shatkay H, Abraham MR.

Am J Cardiol. 2019 May 15;123(10):1681-1689. doi: 10.1016/j.amjcard.2019.02.022. Epub 2019 Feb 27.

3.

Low Left Atrial Strain Is Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy Patients.

Vasquez N, Ostrander BT, Lu DY, Ventoulis I, Haileselassie B, Goyal S, Greenland GV, Vakrou S, Olgin JE, Abraham TP, Abraham MR.

J Am Soc Echocardiogr. 2019 May;32(5):593-603.e1. doi: 10.1016/j.echo.2019.01.007. Epub 2019 Mar 20.

PMID:
30904367
4.

Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.

Sivalokanathan S, Zghaib T, Greenland GV, Vasquez N, Kudchadkar SM, Kontari E, Lu DY, Dolores-Cerna K, van der Geest RJ, Kamel IR, Olgin JE, Abraham TP, Nazarian S, Zimmerman SL, Abraham MR.

JACC Clin Electrophysiol. 2019 Mar;5(3):364-375. doi: 10.1016/j.jacep.2018.10.016. Epub 2018 Dec 26.

5.

Left ventricular mechanical dispersion predicts arrhythmic risk in mitral valve prolapse.

Ermakov S, Gulhar R, Lim L, Bibby D, Fang Q, Nah G, Abraham TP, Schiller NB, Delling FN.

Heart. 2019 Jul;105(14):1063-1069. doi: 10.1136/heartjnl-2018-314269. Epub 2019 Feb 12.

6.

Interobserver Variability in Applying American Society of Echocardiography/European Association of Cardiovascular Imaging 2016 Guidelines for Estimation of Left Ventricular Filling Pressure.

Nagueh SF, Abraham TP, Aurigemma GP, Bax JJ, Beladan C, Browning A, Chamsi-Pasha MA, Delgado V, Derumeaux G, Dolci G, Donal E, Edvardsen T, El Tallawi KC, Ernande L, Esposito R, Flachskampf FA, Galderisi M, Gentry J, Goldstein SA, Harb SC, Hubert A, Hung J, Klein AL, Lancellotti P, Mahmood RZ, Marino P, Popescu BA, Previato M, Sanghai SR, Smiseth OA, Xu J; for Diastolic Function Assessment Collaborators.

Circ Cardiovasc Imaging. 2019 Dec;12(1):e008122. doi: 10.1161/CIRCIMAGING.118.008122.

PMID:
30632389
7.

Corrigendum to Defining the Role of Point-of-Care Ultrasound in Cardiovascular Disease [The American Journal of Cardiology 122 (2018) 1443-1450].

Kovell LC, Ali MT, Hays AG, Metkus TS, Madrazo JA, Corretti MC, Mayer S, Abraham TP, Shapiro EP, Mukherjee M.

Am J Cardiol. 2019 Feb 15;123(4):706-707. doi: 10.1016/j.amjcard.2018.11.002. Epub 2018 Dec 12. No abstract available.

PMID:
30553511
8.

Higher incidence of vasodilator-induced left ventricular cavity dilation by PET when compared to treadmill exercise-ECHO in hypertrophic cardiomyopathy.

Lu DY, Yalçin H, Sivalokanathan S, Greenland GV, Vasquez N, Yalçin F, Zhao M, Valenta I, Ganz P, Pampaloni MH, Zimmerman S, Schindler TH, Abraham TP, Abraham MR.

J Nucl Cardiol. 2018 Nov 19. doi: 10.1007/s12350-018-01521-x. [Epub ahead of print]

PMID:
30456498
9.

Defining the Role of Point-of-Care Ultrasound in Cardiovascular Disease.

Kovell LC, Ali MT, Hays AG, Metkus TS, Madrazo JA, Corretti MC, Mayer SA, Abraham TP, Shapiro EP, Mukherjee M.

Am J Cardiol. 2018 Oct 15;122(8):1443-1450. doi: 10.1016/j.amjcard.2018.06.054. Epub 2018 Jul 19. Review. Erratum in: Am J Cardiol. 2019 Feb 15;123(4):706-707.

PMID:
30115421
10.

Diastolic dysfunction is common and predicts outcome after cardiac surgery.

Metkus TS, Suarez-Pierre A, Crawford TC, Lawton JS, Goeddel L, Dodd-O J, Mukherjee M, Abraham TP, Whitman GJ.

J Cardiothorac Surg. 2018 Jun 15;13(1):67. doi: 10.1186/s13019-018-0744-3.

11.

Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy.

Lu DY, Yalçin H, Yalçin F, Zhao M, Sivalokanathan S, Valenta I, Tahari A, Pomper MG, Abraham TP, Schindler TH, Abraham MR.

Am J Cardiol. 2018 May 1;121(9):1081-1089. doi: 10.1016/j.amjcard.2018.01.022. Epub 2018 Feb 6.

12.

Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging.

Badano LP, Kolias TJ, Muraru D, Abraham TP, Aurigemma G, Edvardsen T, D'Hooge J, Donal E, Fraser AG, Marwick T, Mertens L, Popescu BA, Sengupta PP, Lancellotti P, Thomas JD, Voigt JU; Industry representatives; Reviewers: This document was reviewed by members of the 2016–2018 EACVI Scientific Documents Committee.

Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):591-600. doi: 10.1093/ehjci/jey042. Review. Erratum in: Eur Heart J Cardiovasc Imaging. 2018 Jul 1;19(7):830-833.

13.

Allele-specific differences in transcriptome, miRNome, and mitochondrial function in two hypertrophic cardiomyopathy mouse models.

Vakrou S, Fukunaga R, Foster DB, Sorensen L, Liu Y, Guan Y, Woldemichael K, Pineda-Reyes R, Liu T, Tardiff JC, Leinwand LA, Tocchetti CG, Abraham TP, O'Rourke B, Aon MA, Abraham MR.

JCI Insight. 2018 Mar 22;3(6). pii: 94493. doi: 10.1172/jci.insight.94493.

14.

Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.

Lu DY, Pozios I, Haileselassie B, Ventoulis I, Liu H, Sorensen LL, Canepa M, Phillip S, Abraham MR, Abraham TP.

J Am Heart Assoc. 2018 Feb 25;7(5). pii: e006657. doi: 10.1161/JAHA.117.006657.

15.

Rest and Stress Longitudinal Systolic Left Ventricular Mechanics in Hypertrophic Cardiomyopathy: Implications for Prognostication.

Pozios I, Pinheiro A, Corona-Villalobos C, Sorensen LL, Dardari Z, Liu HY, Cresswell K, Phillip S, Bluemke DA, Zimmerman SL, Abraham MR, Abraham TP.

J Am Soc Echocardiogr. 2018 May;31(5):578-586. doi: 10.1016/j.echo.2017.11.002. Epub 2018 Feb 14.

PMID:
29426649
16.

Correction to: Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy.

Yalcin H, Valenta I, Zhao M, Tahari A, Lu DY, Higuchi T, Yalcin F, Kucukler N, Soleimanifard Y, Zhou Y, Pomper MG, Abraham TP, Tsui B, Lodge MA, Schindler TH, Abraham MR.

J Nucl Cardiol. 2019 Aug;26(4):1254. doi: 10.1007/s12350-018-1228-5.

PMID:
29423907
17.

Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy.

Yalcin H, Valenta I, Zhao M, Tahari A, Lu DY, Higuchi T, Yalcin F, Kucukler N, Soleimanifard Y, Zhou Y, Pomper MG, Abraham TP, Tsui B, Lodge MA, Schindler TH, Roselle Abraham M.

J Nucl Cardiol. 2019 Aug;26(4):1243-1253. doi: 10.1007/s12350-017-1155-x. Epub 2018 Jan 22. Erratum in: J Nucl Cardiol. 2018 Feb 8;:.

PMID:
29359273
18.

Evolution of ventricular hypertrophy and myocardial mechanics in physiological and pathological hypertrophy.

Yalçin F, Kucukler N, Cingolani O, Mbiyangandu B, Sorensen L, Pinherio A, Abraham MR, Abraham TP.

J Appl Physiol (1985). 2019 Feb 1;126(2):354-362. doi: 10.1152/japplphysiol.00199.2016. Epub 2018 Jan 4.

PMID:
29357486
19.

Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy.

Lu DY, Hailesealassie B, Ventoulis I, Liu H, Liang HY, Nowbar A, Pozios I, Canepa M, Cresswell K, Luo HC, Abraham MR, Abraham TP.

Int J Cardiol. 2017 Sep 15;243:290-295. doi: 10.1016/j.ijcard.2017.04.039.

PMID:
28747034
20.

Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy.

Liu H, Pozios I, Haileselassie B, Nowbar A, Sorensen LL, Phillip S, Lu DY, Ventoulis I, Luo H, Abraham MR, Abraham TP.

Am J Cardiol. 2017 Aug 15;120(4):670-675. doi: 10.1016/j.amjcard.2017.05.039. Epub 2017 May 30.

PMID:
28687124
21.

Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy.

Hurtado-de-Mendoza D, Corona-Villalobos CP, Pozios I, Gonzales J, Soleimanifard Y, Sivalokanathan S, Montoya-Cerrillo D, Vakrou S, Kamel I, Mormontoy-Laurel W, Dolores-Cerna K, Suarez J, Perez-Melo S, Bluemke DA, Abraham TP, Zimmerman SL, Abraham MR.

J Arrhythm. 2017 Jun;33(3):201-207. doi: 10.1016/j.joa.2016.10.005. Epub 2016 Nov 19.

22.

A Good Heart Is Hard to Find: Even Early in Hypertrophic Cardiomyopathy.

Lu DY, Abraham TP.

Circ Cardiovasc Imaging. 2017 May;10(5). pii: e006325. doi: 10.1161/CIRCIMAGING.117.006325. No abstract available.

PMID:
28476778
23.

Exercise-QTc is associated with diffuse interstitial fibrosis reflected by lower approximated T1 relaxation time in hypertrophic cardiomyopathy patients.

Corona-Villalobos CP, Saha S, Pozios I, Hurtado-de-Mendoza Paz D, Sorensen L, Gonzalez Cordoba J, Dolores-Cerna K, Kamel IR, Mormontoy Laurel W, Bluemke DA, Abraham TP, Zimmerman SL, Abraham MR.

J Electrocardiol. 2017 Jul - Aug;50(4):484-490. doi: 10.1016/j.jelectrocard.2017.02.002. Epub 2017 Feb 12. No abstract available.

PMID:
28292523
24.

The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.

Ho CY, Day SM, Colan SD, Russell MW, Towbin JA, Sherrid MV, Canter CE, Jefferies JL, Murphy AM, Cirino AL, Abraham TP, Taylor M, Mestroni L, Bluemke DA, Jarolim P, Shi L, Sleeper LA, Seidman CE, Orav EJ; HCMNet Investigators.

JAMA Cardiol. 2017 Apr 1;2(4):419-428. doi: 10.1001/jamacardio.2016.5670.

25.

T1 mapping with cardiovascular magnetic resonance: an emerging clinical biomarker.

Canepa M, Vianello PF, Abraham TP.

Heart. 2017 Feb 15;103(4):326. doi: 10.1136/heartjnl-2016-310678. No abstract available.

PMID:
28130438
26.

Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Mast TP, James CA, Calkins H, Teske AJ, Tichnell C, Murray B, Loh P, Russell SD, Velthuis BK, Judge DP, Dooijes D, Tedford RJ, van der Heijden JF, Tandri H, Hauer RN, Abraham TP, Doevendans PA, Te Riele AS, Cramer MJ.

JAMA Cardiol. 2017 Mar 1;2(3):293-302. doi: 10.1001/jamacardio.2016.5034.

PMID:
28097316
27.

Structural and Functional Correlates of Myocardial T1 Mapping in 321 Patients With Hypertrophic Cardiomyopathy.

Chu LC, Corona-Villalobos CP, Halushka MK, Zhang Y, Pozzessere C, Kamel IR, Pozios I, Van Der Geest RJ, Gai N, Abraham RM, Abraham TP, Bluemke DA, Zimmerman SL.

J Comput Assist Tomogr. 2017 Jul/Aug;41(4):653-660. doi: 10.1097/RCT.0000000000000564.

PMID:
27997439
28.

Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.

Sorensen LL, Liang HY, Pinheiro A, Hilser A, Dimaano V, Olsen NT, Hansen TF, Sogaard P, Nowbar A, Pisanello C, Pozios I, Phillip S, Zhou X, Abraham R, Abraham TP.

Am Heart J. 2017 Feb;184:47-54. doi: 10.1016/j.ahj.2016.10.010. Epub 2016 Oct 20.

29.

The E-wave propagation index (EPI): A novel echocardiographic parameter for prediction of left ventricular thrombus. Derivation from computational fluid dynamic modeling and validation on human subjects.

Harfi TT, Seo JH, Yasir HS, Welsh N, Mayer SA, Abraham TP, George RT, Mittal R.

Int J Cardiol. 2017 Jan 15;227:662-667. doi: 10.1016/j.ijcard.2016.10.079. Epub 2016 Oct 29.

PMID:
27838120
30.

Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by 13N-Ammonia Perfusion PET in Patients With Hypertrophic Cardiomyopathy.

Yalçin H, Valenta I, Yalçin F, Corona-Villalobos C, Vasquez N, Ra J, Kucukler N, Tahari A, Pozios I, Zhou Y, Pomper M, Abraham TP, Schindler TH, Abraham MR.

Am J Cardiol. 2016 Dec 15;118(12):1908-1915. doi: 10.1016/j.amjcard.2016.08.085. Epub 2016 Sep 15.

PMID:
27771003
31.

Nonobstructive Hypertrophic Cardiomyopathy: Low Mortality but Not Always Benign.

Pozios I, Abraham TP.

J Am Coll Cardiol. 2016 Aug 30;68(9):982-3. doi: 10.1016/j.jacc.2016.04.069. No abstract available.

32.

Echocardiographic Characterization of a Murine Model of Hypertrophic Obstructive Cardiomyopathy Induced by Cardiac-specific Overexpression of Epidermal Growth Factor Receptor 2.

Sørensen LL, Bedja D, Sysa-Shah P, Liu H, Maxwell A, Yi X, Pozios I, Olsen NT, Abraham TP, Abraham R, Gabrielson K.

Comp Med. 2016;66(4):268-77.

33.

Evaluation of Left Ventricular Outflow Tract Obstruction With Four-Dimensional Phase Contrast Magnetic Resonance Imaging in Patients with Hypertrophic Cardiomyopathy-A Pilot Study.

Chu LC, Porter KK, Corona-Villalobos CP, Gülsün MA, Shea SM, Markl M, Abraham TP, Bluemke DA, Kamel IR, Zimmerman SL.

J Comput Assist Tomogr. 2016 Nov/Dec;40(6):937-940.

PMID:
27529682
34.

Unique Abnormalities in Right Ventricular Longitudinal Strain in Systemic Sclerosis Patients.

Mukherjee M, Chung SE, Ton VK, Tedford RJ, Hummers LK, Wigley FM, Abraham TP, Shah AA.

Circ Cardiovasc Imaging. 2016 Jun;9(6). pii: e003792. doi: 10.1161/CIRCIMAGING.115.003792. Epub 2016 Jun 7.

35.

Common miR-590 Variant rs6971711 Present Only in African Americans Reduces miR-590 Biogenesis.

Lin X, Steinberg S, Kandasamy SK, Afzal J, Mbiyangandu B, Liao SE, Guan Y, Corona-Villalobos CP, Matkovich SJ, Epstein N, Tripodi D, Huo Z, Cutting G, Abraham TP, Fukunaga R, Abraham MR.

PLoS One. 2016 May 19;11(5):e0156065. doi: 10.1371/journal.pone.0156065. eCollection 2016.

36.

Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly.

Canepa M, Pozios I, Vianello PF, Ameri P, Brunelli C, Ferrucci L, Abraham TP.

Heart. 2016 Jul 15;102(14):1087-94. doi: 10.1136/heartjnl-2015-308764. Epub 2016 Apr 27. Review.

37.

Comparison of Clinical Features in Blacks Versus Whites With Hypertrophic Cardiomyopathy.

Sorensen LL, Pinheiro A, Dimaano VL, Pozios I, Nowbar A, Liu H, Luo HC, Lin X, Olsen NT, Hansen TF, Sogaard P, Abraham MR, Abraham TP.

Am J Cardiol. 2016 Jun 1;117(11):1815-20. doi: 10.1016/j.amjcard.2016.03.017. Epub 2016 Mar 19.

PMID:
27084053
38.

Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.

Corona-Villalobos CP, Sorensen LL, Pozios I, Chu L, Eng J, Abraham MR, Abraham TP, Kamel IR, Zimmerman SL.

Int J Cardiovasc Imaging. 2016 Jun;32(6):945-54. doi: 10.1007/s10554-016-0858-4. Epub 2016 Feb 19.

PMID:
26896038
39.

Shape analysis of hypertrophic and hypertensive heart disease using MRI-based 3D surface models of left ventricular geometry.

Ardekani S, Jain S, Sanzi A, Corona-Villalobos CP, Abraham TP, Abraham MR, Zimmerman SL, Wu KC, Winslow RL, Miller MI, Younes L.

Med Image Anal. 2016 Apr;29:12-23. doi: 10.1016/j.media.2015.11.004. Epub 2015 Dec 10.

40.

Pacemaker-induced transient asynchrony suppresses heart failure progression.

Kirk JA, Chakir K, Lee KH, Karst E, Holewinski RJ, Pironti G, Tunin RS, Pozios I, Abraham TP, de Tombe P, Rockman HA, Van Eyk JE, Craig R, Farazi TG, Kass DA.

Sci Transl Med. 2015 Dec 23;7(319):319ra207. doi: 10.1126/scitranslmed.aad2899.

41.

Sildenafil treatment attenuates ventricular remodeling in an experimental model of aortic regurgitation.

Eskesen K, Olsen NT, Dimaano VL, Fritz-Hansen T, Sogaard P, Chakir K, Steenbergen C, Kass D, Abraham TP.

Springerplus. 2015 Oct 13;4:592. doi: 10.1186/s40064-015-1317-8. eCollection 2015.

42.

MPST but not CSE is the primary regulator of hydrogen sulfide production and function in the coronary artery.

Kuo MM, Kim DH, Jandu S, Bergman Y, Tan S, Wang H, Pandey DR, Abraham TP, Shoukas AA, Berkowitz DE, Santhanam L.

Am J Physiol Heart Circ Physiol. 2016 Jan 1;310(1):H71-9. doi: 10.1152/ajpheart.00574.2014. Epub 2015 Oct 30.

43.

Current obstacles in management of hypertensive patients by performance-based care and importance of diagnostic tests.

Yalçin F, Abraham TP, Garcia MJ.

Int J Cardiol Heart Vasc. 2015 Oct 20;9:73-74. doi: 10.1016/j.ijcha.2015.10.006. eCollection 2015 Dec 7. No abstract available.

44.

Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy.

Pozios I, Corona-Villalobos C, Sorensen LL, Bravo PE, Canepa M, Pisanello C, Pinheiro A, Dimaano VL, Luo H, Dardari Z, Zhou X, Kamel I, Zimmerman SL, Bluemke DA, Abraham MR, Abraham TP.

Am J Cardiol. 2015 Sep 15;116(6):938-44. doi: 10.1016/j.amjcard.2015.06.018. Epub 2015 Jun 26.

45.

A Summary of the American Society of Echocardiography Foundation Value-Based Healthcare: Summit 2014: The Role of Cardiovascular Ultrasound in the New Paradigm.

Byrd BF 3rd, Abraham TP, Buxton DB, Coletta AV, Cooper JH, Douglas PS, Gillam LD, Goldstein SA, Graf TR, Horton KD, Isenberg AA, Klein AL, Kreeger J, Martin RP, Nedza SM, Navathe A, Pellikka PA, Picard MH, Pilotte JC, Ryan TJ, Rychik J, Sengupta PP, Thomas JD, Tucker L, Wallace W, Ward RP, Weissman NJ, Wiener DH, Woodruff S.

J Am Soc Echocardiogr. 2015 Jul;28(7):755-69. doi: 10.1016/j.echo.2015.05.007. Review.

PMID:
26140937
46.

Late gadolinium enhancement confined to the right ventricular insertion points in hypertrophic cardiomyopathy: an intermediate stage phenotype?

Bravo PE, Luo HC, Pozios I, Zimmerman SL, Corona-Villalobos CP, Sorensen L, Kamel IR, Bluemke DA, Wahl RL, Abraham MR, Abraham TP.

Eur Heart J Cardiovasc Imaging. 2016 Mar;17(3):293-300. doi: 10.1093/ehjci/jev154. Epub 2015 Jun 14.

47.

Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms.

Bravo PE, Tahari A, Pozios I, Luo HC, Bengel FM, Wahl RL, Abraham MR, Abraham TP.

J Nucl Cardiol. 2016 Dec;23(6):1304-1314. Epub 2015 May 20.

PMID:
25989730
48.

Hypertension should be ruled out in patients with hyperdynamic left ventricle on radionuclide myocardial perfusion imaging, diastolic dysfunction and dyspnea on exertion.

Yalçin F, Schindler T, Abraham TP.

Int J Cardiol Heart Vasc. 2015 Apr 9;7:149-150. doi: 10.1016/j.ijcha.2015.04.004. eCollection 2015 Jun 1. No abstract available.

49.

Could early septal involvement in the remodeling process be related to the advance hypertensive heart disease?

Yalçin F, Topaloglu C, Kuçukler N, Ofgeli M, Abraham TP.

Int J Cardiol Heart Vasc. 2015 Apr 8;7:141-145. doi: 10.1016/j.ijcha.2015.04.003. eCollection 2015 Jun 1.

50.

Exercise heart rates in patients with hypertrophic cardiomyopathy.

Luo HC, Dimaano VL, Kembro JM, Hilser A, Hurtado-de-Mendoza D, Pozios I, Tomas MS, Yalcin H, Dolores-Cerna K, Mormontoy W, Aon MA, Cameron D, Bluemke DA, Stewart KJ, Russell SD, Cordova JG, Abraham TP, Abraham MR.

Am J Cardiol. 2015 Apr 15;115(8):1144-1150. doi: 10.1016/j.amjcard.2015.01.548. Epub 2015 Feb 4.

Supplemental Content

Loading ...
Support Center